Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice

Diabetes, Obesity and Metabolism

Volumn 9, Issue 1, 2007, Pages 59-64

  Yamanaka, M ^a   Tsuchida, A ^a   Nakagawa, T ^a   Nonomura, T ^a   Ono Kishino, M ^a   Sugaru, E ^a   Noguchi, H ^a   Taiji, Mutsuo ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Brain derived neurotrophic factor (BDNF); Glucose utilization; Norepinephrine content; Obese diabetic mice (db db)

Indexed keywords

CARBON 14; DEOXYGLUCOSE; GLUCOSE; NORADRENALIN; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIAPHRAGM; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART; IN VIVO STUDY; LIVER; MALE; MOUSE; MOUSE STRAIN; NEUROMODULATION; NONHUMAN; SKELETAL MUSCLE; SOLEUS MUSCLE; TISSUE LEVEL;

EID: 33845525630     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00572.x     Document Type: Article

References (27)

1. Lindsay RM, Wiegand SJ, Altar CA et al. Neurotrophic factors: From molecule to man. Trends Neurosci 1994; 17: 182-190.
2. Skup MH. BDNF and NT-3 widen the scope of neurotrophin activity: pharmacological implications. Acta Neurobiol Exp (Warsz) 1994; 54: 81-94.
3. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell Biol 1995; 7: 148-155.
4. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996; 19: 289-317.
5. Thoenen H, Castrén E, Berzaghi M et al. Recent advances in the treatment of neurodegenerative disorders and cognitive dysfunction. In: Racagni G, Brunello N, Langer SZ eds. Int Acad Biomed Drug Res. Basel: Karger, 1994; 7: 197-203.
6. Sendtner M, Holtman B, Hughes RA. The response of motoneurons to neurotrophins. Neurochem Res 1996; 21: 831-841.
7. Yuen EC, Mobley WC. Therapeutic potential of neurotrophic factors for neurological disorders. Ann Neurol 1996; 40: 346-354.
8. Ono M, Ichihara J, Nonomura T et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun 1997; 238: 633-637.
9. db mice. Diabetes 1999; 48: 588-594.
10. Ono M, Itakura Y, Nonomura T et al. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism 2000; 49: 129-133.
11. Nakagawa T, Tsuchida A, Itakura Y et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000; 49: 436-444.
12. Tsuchida A, Nakagawa T, Itakura Y et al. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia 2001; 44: 555-566.
13. Kahn CR, Neville DM Jr, Roth J. Insulin receptor interaction in the obese hyperglycemic mouse. A model of insulin resistance. J Biol Chem 1973; 248: 244-250.
14. Folli F, Saad MJA, Backer JM et al. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 1993; 92: 1787-1794.
15. Kerouz NJ, Hörsch D, Pons S et al. Differential regulation of insulin receptor substrate-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 1997; 100: 3164-3172.
16. Tsuchida A, Nonomura T, Ono-Kishino M et al. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes 2001; 25: 1286-1293.
17. Kuroda A, Yamasaki Y, Matsuhisa M et al. Brain-derived neurotrophic factor ameliorates hepatic insulin resistance in Zucker fatty rats. Metabolism 2003; 52: 203-208.
18. Nonomura T, Tsuchida T, Ono-Kishino M et al. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int J Exp Diabetes Res 2001; 2: 201-209.
19. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
20. Campfield LA, Smith FJ, Guisez Y et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
21. Halaas JF, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
22. Pelleymounter MA, Cullen MJ, Baker MB et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
23. Collins S, Kuhn CM, Petro AE et al. Role of leptin in fat regulation. Nature 1996; 380: 677.
24. Kamohara S, Burcelin R, Halaas JL et al. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997; 389: 374-377.
25. Ogawa Y, Masuzaki H, Hosoda K et al. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 1999; 48: 1822-1829.
26. Lyons WE, Mamounas LA, Ricaurte GA et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999; 96: 15239-15244.
27. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000; 19: 1290-1300.